1 / 26

Clinical applications of auto antibodies

Clinical applications of auto antibodies. Brig Tahir Aziz Ahmed Consultant Immunologist Armed Forces Institute of Pathology (AFIP) Rawalpindi-Pakistan. Dr Paul Ehrlich. 1854-1915 German Nobel laureate Diphtheria antiserum (with von Boehring) only Boehring won Nobel prize-1901

pulliamb
Télécharger la présentation

Clinical applications of auto antibodies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical applications of auto antibodies Brig Tahir Aziz Ahmed Consultant Immunologist Armed Forces Institute of Pathology (AFIP) Rawalpindi-Pakistan

  2. Dr Paul Ehrlich • 1854-1915 • German • Nobel laureate • Diphtheria antiserum (with von Boehring) only Boehring won Nobel prize-1901 Ehrlich won it for Salvarsan a treatment for Syphilis-five years later • Side-chain theory • Dr Paul Ehrlich’s magic bullet 1945

  3. Auto antibodies • Horror autotoxicus • Auto antibodies relatively easy to detect • Some well defined disease and subset associations • Some auto antibodies with defined role in immunopathogenesis • Antibody levels may relate with disease activity

  4. Thyroid • Thyroid • Anti thyroid peroxidase antibodies (anti thyroid microsomal antibodies) • Anti thyroglobulin antibodies • Anti TSH receptor antibodies • Activating antibodies (Grave’s ophthalmopathy) • Inhibitory antibodies (thyrotropin binding inhibitory immunoglobulins TBII-Thyroiditis)

  5. Anti thyroid microsomal & thyroglobulin antibodies

  6. Anti Thyroglobulin antibodies < 100 IU/ml Normal > 100 IU/ml Elevated 100-500 IU/ml High 501-1000 IU/ml Very high >1000 IU/ml Extremely high (103 positive out of 248. One year local unpublished data)

  7. Anti thyroid peroxidase antibodies < 30 IU/ml Normal 30-300 IU/ml High >300 IU/ml Very high (109 positive out of 496. One year local data unpublished)

  8. When to test for thyroid antibodies • Autoimmune thyroid disease • Grave’s disease • Hashimotos thyroiditis • Postpartum thyroiditis (OR: 11.5) • Idiopathic painless thyroiditis • Thyroglobulin monitoring in thyroid cancer • Recurrent miscarraige (OR: 3.73) • Unexplained subfertility (OR: 1.5) • Preterm birth (OR: 1.9) • Autoimmune polyendocrine syndromes

  9. Anti thyroid antibodies in subclinical hypothyroidism TPO Abs positive: 11.2% of 1500 euthyroid pregnant Pakistani women Miscarriage rate: 36.3% (1.8% in Ab neg women) Prematurity: 26.8% (8% in Ab neg women) (Ghaffor F et al. JCPSP 2006: 16(7); 468-471) • Anti thyroid antibodies in population surveys • Overt hypothyroidism, Thyrotoxicosis = 0.4% • Subclinical hypothyroidism = 4.0% • TPO antibodies 8.6% males; 18.5% females (Hoodgendoorn et al. Clin Chemistry 2006: 52(1); 104-111)

  10. Pregnancy loss • Anti cardiolipin antibodies IgG, IgA, IgM • Anti beta-2 glycoprotien 1 antibodies IgG, IgA, IgM • Lupus anti coagulant test Test to be positive with an interval of 8 weeks

  11. Infertility • Anti sperm agglutinating antibodies (12 /83) • Anti sperm cytotoxic antibodies (Microagglutinating and complement mediated cytotoxicity tests) • Anti ovarian cell antibodies (Indirect immunofluoroscence-ovarian tissue)

  12. Anti parathyroid antibodies (Indirect immunofluorescence-parathyroid tissue) • 38% Idiopathic hypoparathyroidism • 26% Idiopathic addison’s diseases • 12% Hashimoto’s thyroiditis • 6% Control group Blizzard RM. Clin. exp. Immunol. (1966) 1, 119-128. • Anti calcium sensor receptor antibodies (Anti CaSR antibodies. Activating; inhibitory) (Brown EM. Endocrinol Metab Clin North Am. 2009 June ; 38(2): 437-) • Anti pituitary antibodies

  13. Interferon and antibodies • Seven out of 50 patients after interferon treatment developed thyroid dysfunction (Hypothyroid: 5; Hyperthyroid: 2) (Chaudhry N et al. PAFMJ 2011.) (Chutto MA et al. JCPSP 2009.) • Antibodies after interferon treatment TPO (p=0.036); ANA (p=0.014) Chronic HCV infected patients (32/106; 30%) Interferon treatment (22/36; 61%) No treatment (12/32; 37.5%) increase in autoimmunity significant in males: p=<.04 (accepted for publication: Ahmad D et al. PAFMJ 2012;..)

  14. Autoantibodies in liver disease

  15. Autoimmune hepatitis • AFIP data (March 2010-March 2011) • Smooth muscle antibodies 397 38 • SLA 11 1 • LKM 307 3 • AMA 275 5 • Anti parietal cell antibodies (Ahmed D et al. Pakistan J of Pathology 2009; 20(3): 70-73)

  16. Anti pancreatic duct antibodies

  17. Autoimmune pancreatitis • IgG4 antibody levels • Anti pancreatic duct antibodies

  18. Anti parietal cell antibodies

  19. Anti parietal cell antibodies Atrophic gastritis & pernicious anemia (3 positive out of 46) • Anti intrinsic factor antibodies (0 positive out of 27) • 12 patients positive for anti intrinsic factor antibodies out of 78 vitamin B12 deficient patients (local study unpublished data)

  20. Anti islet cell antibodies

  21. Total Positive • Anti islet cell antibodies 10 0 1st degree relatives of IDDM • Anti insulin antibodies 1st degree relatives of IDDM Insulin resistance

  22. Anti adrenal antibodies • Addisons disease • 50% of idiopathic addison’s disease (Brown RM. Clin. exp. Immunol. (1967) 2, 19-30.) • 83% of primary addison’s disease positive for anti adrenal antibodies (IF) • 100% positive for anti 21-alpha hyroxylase antibodies in autoimmune addison’s disease (Betterle C et al.Endocrine Reviews 2002. 23(3):327–364) • Premature ovarian failure • 3.2%positive for anti adrenal antibodies

  23. Anti adrenal antibodies • APS type 1 13% • APS type 2 41% • APS type 4 5% • Isolated autoimmune adrenal disease 41% (Betterle C et al.Endocrine Reviews 2002. 23(3):327–364)

  24. Autoimmune polyendocrine syndrome, type 1. candidiasis-hypoparathyroidism-Addison's disease-syndrome, Autoimmune Polyglandular Syndrome I,[2] APECED, or APS-I Other disease associations are: • hypothyroidism • hypogonadism and infertility • vitiligo (depigmentation of the skin) • alopecia (baldness) • malabsorption • pernicious anemia • chronic active (autoimmune) hepatitis Autoimmune polyendocrine syndrome, type II.  autoimmune adrenal insufficiency autoimmune thyroid disease and/or type 1 autoimmune diabetes mellitus defines

  25. Conclusion • Auto antibodies remain the only test to identify autoimmune nature of endocrine diseases. • Auto antibodies may be tested using relatively simple laboratory techniques to help establish the diagnosis of relatively rare diseases.

More Related